Formula Systems Reports Record Revenue Growth and Announces New Shareholder Dividend for 2026

In Q2, operating income benefited from a $16.6 million capital gain resulting from the dilution of its stake in affiliate TSG.
Formula Systems reported equity attributable to shareholders of about $1.21 billion and maintained negative net financial indebtedness with strong covenant coverage on its debentures.
For the first half of 2026, net income attributable to Formula’s shareholders rose about 71.4% to $58.9 million, with Q2 diluted earnings per share of $1.47 and H1 diluted EPS of $3.72.
The reported results exclude discontinued operations of the former subsidiary Sapiens, providing a clearer view of ongoing operations.
Formula Systems reported record earnings for the second quarter and first half of 2026, with Q2 revenues jumping 29.8% year over year to $782.4 million TipRanks. Net income attributable to shareholders surged 54.6% in Q2 alone, while the company declared a $1.63 per share dividend payable in October 2026 to reward investors QuiverQuant.
The strong results reflect Formula's diversified portfolio across subsidiaries like Matrix and Michpal Technologies ScanX. Despite robust growth, an AI analyst at TipRanks rated the stock Neutral, citing solid cash flow but warning of weak technical indicators and concerns about non-recurring income gains.
Formula Systems' first-half 2026 revenues hit $1.52 billion, up 24.4% from the prior year QuiverQuant. Q2 alone delivered $782.4 million in sales, marking the company's strongest quarter on record MarketScreener. This performance reflects strong demand across its global IT solutions and professional services portfolio.
Operating income climbed roughly 53.3% in the first half, significantly outpacing revenue growth and showing improved operational efficiency MarketScreener. The company credited its diversified subsidiary network with driving consistent profitability across multiple business segments.
Net income attributable to shareholders rose 71.4% in H1 2026 to $58.9 million, partly lifted by a $16.6 million capital gain from diluting its stake in affiliate company TSG QuiverQuant. Q2 diluted earnings per share reached $1.47, with H1 diluted EPS of $3.72. This gain inflated year-over-year comparisons and contributed to investor scrutiny.
The company separately reported results excluding discontinued operations from former subsidiary Sapiens, providing a clearer picture of ongoing business performance MarketScreener. This accounting adjustment helps investors assess core operations independently from one-time asset movements.
Formula maintains solid liquidity with cash and deposits totaling approximately $864.5 million TipRanks. The company holds negative net financial indebtedness, meaning it has more cash than debt, and maintains strong covenant coverage on its debentures QuiverQuant. Shareholder equity reached about $1.21 billion, reinforcing financial stability.
The board declared a $1.63 per share dividend for October 2026 payout, totaling approximately $25 million TipRanks. This capital return signals management confidence in sustained cash generation and commitment to shareholder returns amid record profitability.
An AI-powered analyst note cited by TipRanks assigned Formula Systems a Neutral rating despite acknowledging solid cash generation and favorable valuation metrics. The analyst flagged weak technical chart patterns and concerns that non-recurring income gains masked underlying operational sustainability.
Management guided for continued profitable growth in H2 2026, backed by operational excellence across its subsidiary network QuiverQuant. However, investors should monitor whether H2 results sustain the growth trajectory absent similar one-time capital gains from affiliate transactions.
Publishers
13
Articles
13
Reach
26